• Register
  • Login

Iranian Journal of Dermatology

  1. Home
  2. Ellagic acid can be possible adjuvant treatment for COVID- 19 disease

Current Issue

By Issue

By Author

By Subject

Author Index

Keyword Index

About Journal

Aims and Scope

Editorial Board

Publication Ethics

Indexing and Abstracting

Related Links

FAQ

Peer Review Process

Journal Metrics

News

Ellagic acid can be possible adjuvant treatment for COVID- 19 disease

Document Type : Letter to Editor

Authors

  • Mohamad Reza Namazi 1, 2
  • Nasrin Saki 1, 2
  • Maryam Hadibarhaghtalab 1, 2

1 Department of Dermatology, Shiraz University of Medical Sciences, Shiraz, Iran

2 Molecular Dermatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

https://doi.org/10.22034/ijd.2020.239431.1163

Keywords

  • Ellagic acid
  • adjuvant treatment
  • COVID- 19 disease
Iranian Journal of Dermatology
Volume 23, Suppl.1(COVID-19)
2020
Pages 76-77
Files
  • XML
  • PDF 168.1 K
Share
How to cite
  • RIS
  • EndNote
  • Mendeley
  • BibTeX
  • APA
  • MLA
  • HARVARD
  • VANCOUVER
Statistics
  • Article View: 228
  • PDF Download: 323

APA

Namazi, M. R., Saki, N., & Hadibarhaghtalab, M. (2020). Ellagic acid can be possible adjuvant treatment for COVID- 19 disease. Iranian Journal of Dermatology, 23(Suppl.1(COVID-19)), 76-77. doi: 10.22034/ijd.2020.239431.1163

MLA

Mohamad Reza Namazi; Nasrin Saki; Maryam Hadibarhaghtalab. "Ellagic acid can be possible adjuvant treatment for COVID- 19 disease". Iranian Journal of Dermatology, 23, Suppl.1(COVID-19), 2020, 76-77. doi: 10.22034/ijd.2020.239431.1163

HARVARD

Namazi, M. R., Saki, N., Hadibarhaghtalab, M. (2020). 'Ellagic acid can be possible adjuvant treatment for COVID- 19 disease', Iranian Journal of Dermatology, 23(Suppl.1(COVID-19)), pp. 76-77. doi: 10.22034/ijd.2020.239431.1163

VANCOUVER

Namazi, M. R., Saki, N., Hadibarhaghtalab, M. Ellagic acid can be possible adjuvant treatment for COVID- 19 disease. Iranian Journal of Dermatology, 2020; 23(Suppl.1(COVID-19)): 76-77. doi: 10.22034/ijd.2020.239431.1163

  • Home
  • About Journal
  • Editorial Board
  • Submit Manuscript
  • Contact Us
  • Glossary
  • Sitemap

News

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Newsletter Subscription

Subscribe to the journal newsletter and receive the latest news and updates

©